Q1 Earnings Forecast for Beam Therapeutics Issued By Wedbush
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Equities research analysts at Wedbush decreased their Q1 2025 earnings per share estimates for shares of Beam Therapeutics in a note issued to investors on Tuesday, February 25th. Wedbush analyst D. Nierengarten now expects that the company will earn ($1.21) per share for the quarter, down from […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) – Equities research analysts at Wedbush decreased their Q1 2025 earnings per share estimates for shares of Beam Therapeutics in a note issued to investors on Tuesday, February 25th. Wedbush analyst D. Nierengarten now expects that the company will earn ($1.21) per share for the quarter, down from […]
